SOX2 and neoplasm: For example, Lee et al and Santini et al determined that stable knockdown of SOX2 in limiting cell dilution tumor assays dramatically reduced tumor initiation/formation in both head and neck squamous cell carcinomas and melanomas, respectively [49, 78].